AMGEN INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 270 USD | +0.22% |
|
+0.39% | -6.26% |
| 04-26 | Amgen to Submit Thyroid Eye Disease Treatment Marketing Authorization Application in Europe | MT |
| 04-26 | Amgen to Seek European OK of Thyroid Eye Disease Drug Tepezza | DJ |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 145B | ||||||
| 661B | ||||||
| 566B | ||||||
| 352B | ||||||
| 332B | ||||||
| 283B |
- Stock Market
- Equities
- AMGN Stock
- Charts Amgen Inc.
- Sector Chart
